Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up

BioCentury This Week

English - February 21, 2023 23:00 - 21 minutes - 14.9 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. 161 - New Cancer Paradigms, Distilling Innovations, & IPOs

Next Episode: Ep. 163 - EU Pharma Law Overhaul, Abortion Drug Ruling, Dunn's Departure

On the latest BioCentury This Week podcast, BioCentury’s editors discuss what the latest payment models from CMS could mean for cell and gene therapies, and how a new model could incentivize the completion of confirmatory trials for drugs with accelerated approval. BioCentury's editors also discuss the outlook for China's public markets and details around the genetic medicine delivery technology of recently launched Aera Therapeutics.